Related Experiment Video

Updated: Apr 18, 2026

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
06:44

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

Published on: April 28, 2021

4.7K

DNA double-strand break repair inhibitors as cancer therapeutics

Mrinal Srivastava1, Sathees C Raghavan1

  • 1Department of Biochemistry, Indian Institute of Science, Bangalore, 560 012, India.

Chemistry & Biology
|January 13, 2015
PubMed

Insights

Targeting DNA double-strand break (DSB) repair pathways is crucial for cancer treatment. Inhibiting these repair mechanisms can enhance the efficacy of chemotherapy and radiotherapy, offering a promising strategy for cancer elimination.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • DNA double-strand breaks (DSBs) are highly cytotoxic DNA lesions.
  • Defective DSB repair leads to genomic instability and cancer development.
  • DSB repair pathways, including homologous recombination (HR) and nonhomologous end joining (NHEJ), are critical for cell survival.

Purpose of the Study:

  • To review the significance of targeting DSB repair pathways in cancer therapy.
  • To discuss the role of DSB repair gene alterations in cancer and treatment resistance.
  • To highlight recent advancements in DSB repair inhibitors and their clinical applications.

Main Methods:

  • Literature review of scientific articles and clinical trial data.
  • Analysis of the mechanisms of DSB repair pathways.
  • Examination of the impact of DSB repair inhibitors on cancer cells and tumors.

Main Results:

  • Altered expression of DSB repair genes is observed in various cancers.
  • Activation of DSB repair pathways contributes to chemo- and radioresistance.
  • Inhibiting DSB repair can potentiate the efficacy of cancer treatments by blocking residual repair.

Conclusions:

  • Targeting DSB repair pathways presents a viable strategy for cancer treatment.
  • Development of DSB repair inhibitors shows promise for clinical application.
  • Blocking DNA repair mechanisms can overcome therapeutic resistance in cancer.

More Related Videos

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response05:01

Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response

Published on: June 14, 2024

2.5K
Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

4.2K

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
94
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

The double-stranded structure of DNA has two major advantages. First, it serves as a safe repository of genetic information where one strand serves as the back-up in case the other strand is damaged. Second, the double-helical structure can be wrapped around proteins called histones to form nucleosomes, which can then be tightly wound to form chromosomes. This way, DNA chains up to 2 inches long can be contained within microscopic structures in a cell. A double-stranded break not only damages...
16.4K
Fixing Double-strand Breaks02:04

Fixing Double-strand Breaks

4.8K
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.4K
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K